Med School: Separating Hype from Hope in Genome Science

Setup

Genomic discoveries were supposed to transform medicine and move us to a new vision of preventive health care. But 15 years after the Human Genome Project was complete, that still hasn’t happened. Meanwhile, direct-to-consumer genetics companies are bypassing health care providers to market ancestry, disease risk, diet, exercise and even dating and wine applications directly to the public. Robert Green, one of the world’s leaders in generating the evidence-base for genomic medicine, describes what's right and what’s wrong with the genomic revolution, and how we can realize the promise of precision medicine for all. (Underwritten by America's Biopharmaceutical Companies)

Explore More

Health

445 ideas
Sorry, we couldn't find any results
Clear filters
Med School: Separating Hype from Hope in Genome Science

Thank you for signing up!

Please provide a valid email address.

Please provide a valid email address.
Newsletter
Newsletter
Sign up to our newsletter
for the latest festival updates.